CDC nominee on shaky ground following US Senate confirmation hearing

During a lengthy and tense confirmation hearing, President Trump's nominee for CDC director, Dr. Erica Schwartz, struggled to secure the support needed from U.S. Senate health policy committee members. The contentious debate highlighted deep divisions on public health policy, raising questions about her ability to lead the agency effectively. This uncertainty comes at a critical time when the nation grapples with ongoing public health challenges, underscoring the importance of having a stable and well-supported leadership at the CDC. The outcome of this confirmation process could influence public health strategies and responses in the future.